Research ArticleDrug Discovery and Translational Medicine
Discovery of Anti–Claudin-1 Antibodies as Candidate Therapeutics against Hepatitis C Virus
Mayo Yamashita, Manami Iida, Minoru Tada, Yoshitaka Shirasago, Masayoshi Fukasawa, Shotaro Nagase, Akihiro Watari, Akiko Ishii-Watabe, Kiyohito Yagi and Masuo Kondoh
Journal of Pharmacology and Experimental Therapeutics April 2015, 353 (1) 112-118; DOI: https://doi.org/10.1124/jpet.114.217653
Mayo Yamashita
Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.Y., M.I., S.N., A.W., K.Y., M.K.); Division of Biological Chemistry and Biologicals, National Institutes of Health Sciences, Tokyo, Japan (M.T., A.I.-W.); Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan (Y.S., M.F.); and Graduate School of Biological Science, Tokyo University of Science, Chiba, Japan (Y.S.)
Manami Iida
Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.Y., M.I., S.N., A.W., K.Y., M.K.); Division of Biological Chemistry and Biologicals, National Institutes of Health Sciences, Tokyo, Japan (M.T., A.I.-W.); Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan (Y.S., M.F.); and Graduate School of Biological Science, Tokyo University of Science, Chiba, Japan (Y.S.)
Minoru Tada
Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.Y., M.I., S.N., A.W., K.Y., M.K.); Division of Biological Chemistry and Biologicals, National Institutes of Health Sciences, Tokyo, Japan (M.T., A.I.-W.); Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan (Y.S., M.F.); and Graduate School of Biological Science, Tokyo University of Science, Chiba, Japan (Y.S.)
Yoshitaka Shirasago
Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.Y., M.I., S.N., A.W., K.Y., M.K.); Division of Biological Chemistry and Biologicals, National Institutes of Health Sciences, Tokyo, Japan (M.T., A.I.-W.); Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan (Y.S., M.F.); and Graduate School of Biological Science, Tokyo University of Science, Chiba, Japan (Y.S.)
Masayoshi Fukasawa
Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.Y., M.I., S.N., A.W., K.Y., M.K.); Division of Biological Chemistry and Biologicals, National Institutes of Health Sciences, Tokyo, Japan (M.T., A.I.-W.); Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan (Y.S., M.F.); and Graduate School of Biological Science, Tokyo University of Science, Chiba, Japan (Y.S.)
Shotaro Nagase
Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.Y., M.I., S.N., A.W., K.Y., M.K.); Division of Biological Chemistry and Biologicals, National Institutes of Health Sciences, Tokyo, Japan (M.T., A.I.-W.); Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan (Y.S., M.F.); and Graduate School of Biological Science, Tokyo University of Science, Chiba, Japan (Y.S.)
Akihiro Watari
Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.Y., M.I., S.N., A.W., K.Y., M.K.); Division of Biological Chemistry and Biologicals, National Institutes of Health Sciences, Tokyo, Japan (M.T., A.I.-W.); Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan (Y.S., M.F.); and Graduate School of Biological Science, Tokyo University of Science, Chiba, Japan (Y.S.)
Akiko Ishii-Watabe
Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.Y., M.I., S.N., A.W., K.Y., M.K.); Division of Biological Chemistry and Biologicals, National Institutes of Health Sciences, Tokyo, Japan (M.T., A.I.-W.); Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan (Y.S., M.F.); and Graduate School of Biological Science, Tokyo University of Science, Chiba, Japan (Y.S.)
Kiyohito Yagi
Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.Y., M.I., S.N., A.W., K.Y., M.K.); Division of Biological Chemistry and Biologicals, National Institutes of Health Sciences, Tokyo, Japan (M.T., A.I.-W.); Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan (Y.S., M.F.); and Graduate School of Biological Science, Tokyo University of Science, Chiba, Japan (Y.S.)
Masuo Kondoh
Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.Y., M.I., S.N., A.W., K.Y., M.K.); Division of Biological Chemistry and Biologicals, National Institutes of Health Sciences, Tokyo, Japan (M.T., A.I.-W.); Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan (Y.S., M.F.); and Graduate School of Biological Science, Tokyo University of Science, Chiba, Japan (Y.S.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleDrug Discovery and Translational Medicine
A Claudin-1–Targeted HTA
Mayo Yamashita, Manami Iida, Minoru Tada, Yoshitaka Shirasago, Masayoshi Fukasawa, Shotaro Nagase, Akihiro Watari, Akiko Ishii-Watabe, Kiyohito Yagi and Masuo Kondoh
Journal of Pharmacology and Experimental Therapeutics April 1, 2015, 353 (1) 112-118; DOI: https://doi.org/10.1124/jpet.114.217653
Research ArticleDrug Discovery and Translational Medicine
A Claudin-1–Targeted HTA
Mayo Yamashita, Manami Iida, Minoru Tada, Yoshitaka Shirasago, Masayoshi Fukasawa, Shotaro Nagase, Akihiro Watari, Akiko Ishii-Watabe, Kiyohito Yagi and Masuo Kondoh
Journal of Pharmacology and Experimental Therapeutics April 1, 2015, 353 (1) 112-118; DOI: https://doi.org/10.1124/jpet.114.217653
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement